Når det anvendes sammen med Invirase/ ritonavir, skal der administreres den lavest mulige atorvastatindosis, og patienterne bør kontrolleres omhyggeligt for tegn/ symptomer på myopati (muskelslaphed, muskelsmerter, stigende plasmakreatininkinase).
When used with Invirase/ ritonavir, the lowest possible dose of atorvastatin should be administered and the patient should be carefully monitored for signs/ symptoms of myopathy (muscle weakness, muscle pain, rising plasma creatinine kinase).